Thursday, 31 August 2017

Roche Granted FDA Priority Review for Blood Cancer Treatment


It is aimed at people with untreated follicular lymphoma, Roche said, adding that the cancer is considered incurable. Trial results showed that Gazyva-based treatment significantly lengthened the time between relapses when compared with the current ...and more » #cancertreatment
http://readr.me/unisz


No comments:

Post a Comment